New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Helios and Sunbio publish study in the Journal of Phytotherapy Research

Helios and Sunbio publish study in the Journal of Phytotherapy Research

Helios Corporation and its business partner, Sunbio Corporation recently published its Phase II human clinical study in the Journal of Phytotherapy Research. The clinical data was evaluated by the science panel at P.R. and deemed both acceptable and important to the science community for the treatment of pre-, peri-, and post-menopause. (

EstroG-100 is the number one nutritional ingredient in South Korea. As an ingredient, EstroG-100 has been in the USA market for the past 4 years. During this time, Sunbio accumulated multiple awards for the performance, safety and efficacy of EstroG-100 within the menopausal category. EstroG-100 received a letter of no objection from the United States FDA in 2010, along with a Health Canada Product License Number in 2011 that confirms 10 end point claims based on their review and evaluation of the Phase II human clinical study 

Utilizing the Kupperman Index study model for menopause in the 2010 Phase II human clinical study EstroG-100 showed significant improvement in 9 of 11 end points, along with an additional significant improvement in vaginal dryness. Also, hGH levels increased by 100%, which can be directly attributed to improvements in energy level, skin moisture and tone. Other botanical choices only demonstrate improvements in 2-3 end points utilizing the Kupperman study model.

EstroG-100 is the only botanical ingredient that promises and can prove in 5 toxicity studies safety with no risk of cancer or liver toxicity. Also- most botanicals take 4-6 week to show improvements in menopausal symptoms where as EstroG-100 consistently improved multiple symptoms within 1-2 weeks. EstroG-100 is the most important next generation ingredient for woman experiencing pre-, peri-, and post-menopause.

About Helios CORP and Sunbio:

Helios CORP and Sunbio are privately owned global companies that translate nutritional ideas, cultural remedies and science into ingredients, the commercial applications of which benefit nutrition and food manufacturers as well as consumers. Claims and representations are based on the information, data, clinical studies and remedies provided by our partners in science and manufacturing.


Neogen reports Q1 revenue and net income increases

Neogen reports Q1 revenue and net income increases


Neogen Corporation (Nasdaq: NEOG) announced that its revenues for the first quarter of FY 2012, which ended Aug. 31, increased 6.5% to $45,697,000, from the previous year's first quarter revenues of $42,923,000. The current year's revenue increase is almost entirely comprised of products available in the prior year's first quarter.

First quarter net income increased 3.1% from the prior year to $6,004,000, or $0.25 per share. This compares to net income of $5,824,000 in the first quarter of FY 2011, also $0.25 per share. The first quarter revenues and net income represent quarterly records for the 29-year-old company.

"In the first quarter we continued our remarkable quarter-to-quarter success in consistent growth in sales and profits, while at the same time implementing our plan to ensure long-term growth," said James Herbert, Neogen's chief executive officer and chairman. "I'm very proud of our management team and employee group, who have kept our strong quarter-to-quarter growth going for more than 20 years."

The quarter marked the 74th consecutive profitable quarter from operations for the company, and was the 78th of the past 83 quarters when Neogen reported revenue increases as compared with the previous year — including the last 26 consecutive quarters.

"We are pleased to report yet another solid quarter, in spite of a difficult comparison with our previous fiscal year's first quarter. Last year at this time we reported a first quarter revenue increase of 33% that was bolstered by a significant spike in sales of two test kits primarily resulting from unusual weather conditions," said Lon Bohannon, Neogen's president and chief operating officer. "During the first quarter we were also able to move forward with some infrastructure improvements intended to accelerate future growth, including completing the purchase of a facility in Lexington, Ky., which will greatly expand our Animal Safety operational capabilities, and consolidating our recently acquired VeroMara seafood testing operations in Oban, Scotland, into our expanded Neogen Europe facilities in Ayr, Scotland."

Neogen's gross margin was 50.3% of sales in its first quarter of the current year, compared to 53.0% of sales for FY 2011's first quarter. This decline was largely the result of a shift in product mix towards products in the Animal Safety segment which have lower margins. Neogen again reported operating income, expressed as a percentage of sales, in excess of 20% for the quarter.  

"We generated positive cash flow from operations during the quarter, although our cash and investments position declined by $4,726,000, due primarily to cash utilized to acquire facilities in Lexington, Ky., and the VeroMara business," said Steve Quinlan, Neogen's chief financial officer. "For our operating expenses, sales and marketing increased overall and as a percentage of sales as a part of a planned investment in our sales and marketing infrastructure to better serve our growing domestic and international markets, while general and administrative and research and development expenses decreased as a percentage of sales. The R&D drop was solely due to a decline in contracted outside R&D services in the current year quarter. We remain committed to supporting a strong internal R&D program, and view this decline as a timing issue. With our continuing strong cash position, no long-term debt and full access to a significant bank line of credit, we remain poised to pursue growth strategies."

Neogen's Animal Safety Division led the company's first quarter revenue increase, with sales up 8.4% to $22,415,000 in FY 2012. The quarter saw significant, broad-based increases in sales of the company's agricultural cleaners and disinfectants, especially internationally. Neogen markets its own BioSentry® branded cleaners and disinfectants worldwide, as well as related DuPont™ products in most of the Western Hemisphere. The cleaner and disinfectant market benefitted significantly from Neogen's expanding sales and marketing effort, as the company used additional personnel to strengthen relationships with its distributor partners, and help expand the use of Neogen's products into new markets, such as the greenhouse and aquaculture industries.

Sales of Neogen's animal care products increased 24% in the current quarter. Veterinary instruments were up 26% over the prior year's comparable first quarter, bolstered by new product placements associated with an expanded program with large farm and ranch retailer Tractor Supply Company, and a significant increase in sales of the company's detectable veterinary needles.

Faced with a difficult quarterly comparison, Neogen's Food Safety Division first quarter revenues increased 4.6% to $23,282,000. The division was able to offset the loss of exceptionally high diagnostic sales from the prior year's first quarter with significant increases in the sales of other products, including its Soleris® general microbial detection system, and the expanded line of BetaStar® dairy antibiotic test kits. Neogen recently introduced a new version of its simple dairy antibiotic test, BetaStar High Sensitivity, which was developed specifically to meet the more stringent regulations that exist in certain Eastern European countries, and help to prevent antibiotic residues from entering the food chain.

The company also developed a new Soleris test for the presence of heterotrophic bacteria, such as Pseudomonas, which is a critical factor in the shelf life of fluid dairy products, bottled water, and many other food and personal care products. The Soleris system allows for the accurate detection of spoilage organisms, such as yeast and mold, in a fraction of the time of traditional microbial detection methods.

In the current first quarter, Neogen also recorded significant sales of its Soleris product line into China. The company's Mexican subsidiary recorded a 57% sales increase compared to the prior year with its sales of Neogen's food and animal safety products, and the company continues to see significant revenue growth from its new subsidiary in Brazil. For the first quarter of its 2012 fiscal year, Neogen's percentage of revenues from international sources represented 41.4% of its total revenues.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns, and dehydrated culture media. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.


The first fair-trade Mars bar will hit UK shelves in 2012

The first fair-trade Mars bar will hit UK shelves in 2012

Mars Chocolate and Fairtrade International have announced a new agreement to introduce the first Fairtrade labeled Mars product and to work together to enable farmers to have sustainable livelihoods and substantially increased productivity.

At the heart of the agreement is a shared ambition to make commodity certification that supports sustainable livelihoods for farmers the norm in the cocoa industry. Over the long-term, Mars will explore how best to scale up its purchases of Fairtrade cocoa and will support Fairtrade's continued efforts to develop measures that would allow more confectionery companies to increase their commitments to purchase more Fairtrade cocoa with the aim of impacting the lives of more cocoa farmers than ever before.

As part of the initial phase of the agreement, the first Mars product to carry the FAIRTRADE Mark will be MALTESERS, to appear in stores in 2012 in the UK and Ireland, a move that will contribute more than US$1 million annually in Fairtrade Premium funds for cocoa farmers to invest in their farms, business organizations and communities.

"This agreement is a big step towards fulfilling our shared mission to empower farmers to build vibrant, sustainable livelihoods, and we're very excited to work with Fairtrade on ways to enable commodity certification to scale across the entire industry," said Barry Parkin, Mars Global Chocolate Vice President. "This commitment is our recognition of Fairtrade's history of dedication to smallholder farmers and their efforts to enable farmer productivity and income improvements."

In addition, Fairtrade and Mars will work to take advantage of their common interests and expertise to explore how to improve the productivity, quality, labor and community development benefits they can bring to farmers. Cocoa farmers stand to benefit immensely from the partners' combined experience - Mars' expertise in technical support to improve yield and Fairtrade's expertise in building farmer organizations.

"We're excited about this agreement's potential to transform the lives of thousands of small-scale cocoa farmers," says Rob Cameron, CEO of Fairtrade International. "Through Fairtrade certification, we've seen how farmers' organizations can use the additional investment from Fairtrade cocoa sales to tackle the problems they face - from projects to improve their farming methods and the quality of the cocoa they produce, to schooling for their children and health facilities in their villages. But the needs are still so great. That's why working with Mars is so important - together we have the potential to have real measurable impact on the ground."

Current annual world production of cocoa is around 3.5 million metric tons, and by 2020 the chocolate confectionery industry will need at least 4.5 million metric tons. To satisfy demand, cocoa farmers need industry support to invest in overcoming the challenges of ageing cocoa trees, low productivity and lack of confidence in cocoa farming among the young. Yet as of 2009, certified cocoa represented just over 1% of total purchases.

Mars was the first major confectionery company to commit to purchasing only certified cocoa. In the future, demand for certified cocoa must be met by an efficient, effective and reliable system of farmer training, auditing and supply chain management. Further, a much greater proportion will need to be certified by 2020 to allow the market to bear additional large-scale certified purchasing commitments, and, more importantly, to have a positive impact on many more of the 5 to 6 million farmers who cultivate cocoa.

Both Mars and Fairtrade believe that empowering farmers to drive change is the most effective way to achieve true sustainability. Fairtrade is working with tens of thousands of cocoa farmers in West Africa and, with the additional income from the Fairtrade Premium, Fairtrade farmers' groups have hired agronomists, invested in farm-level productivity and built warehousing and processing facilities. They are funding community development by providing clean water, free health insurance and scholarships for children.

Mars is guided by its principle of creating "mutual benefits" for partners throughout the supply chain, including farmers. Apart from committing to sourcing only certified cocoa by 2020, Mars has also released an annotated map of the cocoa genome into the public domain and will invest heavily in Côte d'Ivoire and other major cocoa producing countries over the next decade to provide hundreds of thousands farmers with the tools, material and training necessary to dramatically increase yield and, by extension, farmer income.

Michael Nkonu, Director of Fairtrade Africa, which represents farmers and producers across Africa, says: "We've been working hard to support and strengthen our networks of Fairtrade certified cocoa farmers in West Africa. Many farmers in the Ivory Coast region are still struggling to re-establish their lives and build up their farms following the recent troubles. This agreement couldn't be more timely, and will help enable a better future for farmers."

For more information see or


Publix recalls spinach dip due to possible listeria risk

Publix recalls spinach dip due to possible listeria risk

Publix Super Markets is issuing a voluntary recall for spinach dip because it may be adulterated with Listeria monocytogenes. The problem was discovered as a result of routine microbial testing conducted by Publix. The 16 ounce containers of prepackaged spinach dip were sold at Publix retail deli departments with a UPC of 41415-00062 and use by date of OCT 10 C1.

Consumption of products containing Listeria monocytogenes can cause serious and sometimes fatal infection in young children, frail or elderly people and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.

No illnesses have been reported to date in connection with this problem.

The spinach dip was sold in Publix grocery stores in Florida. The following counties in Florida did not receive recalled product: Miami-Dade, Broward, Palm Beach, Martin, St. Lucie, Indian River and Okeechobee. Publix stores in Alabama, Georgia, South Carolina and Tennessee are not involved with this recall.

"As part of our commitment to food safety, potentially impacted product has been removed from all store shelves,” said Maria Brous, Publix media and community relations director. "To date, there have been no reported cases of illness. Consumers who have purchased the products in question may return the product to their local store for a full refund. Publix customers with additional questions may call our Consumer Relations department at 1-800-242-1227 or by visiting our website at" Customers can also contact the US Food and Drug Administration at 1-888-SAFEFOOD (1-888-723-3366).

Publix is privately owned and operated by its 147,500 employees, with 2010 sales of $25.1 billion. Currently Publix has 1,038 stores in Florida, Georgia, South Carolina, Alabama and Tennessee. The company has been named one of Fortune's "100 Best Companies to Work for in America" for 14 consecutive years. In addition, Publix’s dedication to superior quality and customer service is recognized as tops in the grocery business, most recently by an American Customer Satisfaction Index survey.

FMF Power Beverage bolsters its Western market reach

FMF Power Beverage bolsters its Western market reach

FMF Power Beverage, the industry’s first all-natural performance energy drink with specific hydration and recovery properties, announced that it has greatly bolstered its market reach by establishing strategic partnerships with two of Southern California’s leading beverage distributors, the Los Angeles-based Haralambos Beverage Company and San Diego’s Crest Beverage. In addition, FMF Power Beverage was recently added to shelves in all 85 Arizona locations of the Tulsa, Okla.-based, QuikTrip convenience store chain.

“The swift endorsement of FMF Power Beverage by both large distributors and key retailers so soon after our soft launch is very exciting, as it exhibits our product’s true validity as an all natural energy drink that provides the ultimate in performance, hydration and recovery” said Frank Kerker, FMF Power Beverage, Chief Power Officer. “It’s clear to us, even at this early stage; the rate of adoption amongst consumers is high. And the recognition of the FMF Power Beverage brand by such well-respected beverage industry distributors and retailers certainly reinforces that point, as well as instills confidence for the future.”

Kerker and FUZE Beverage founder, Lance Collins, have been at the forefront of this recent marked expansion, and these announcements see the company strengthening its position as an all-natural alternative to the myriad of additive and preservative-heavy energy drinks on the market. Remaining well ahead of its early distribution projections, FMF Power Beverage is currently available in California, Arizona, Washington and Oregon markets, with plans of major rollouts in San Francisco, Las Vegas and select Florida markets.

For the latest updates on where FMF POWER will appear next, please visit or

About FMF Power Beverage

FMF Power Beverage is an all-natural, high-powered energy drink containing a proprietary PowerBlend™: an infusion of clean, healthy nutrients, vitamins and antioxidants for immediate energy and sustained performance. FMF POWER’s benefits stem from its four pillars—Energy, Performance, Hydration and Recovery. FMF POWER is available in Citrus Lemonade and Fruit Punch flavors, both ‘Tunnel pasteurized’ to preserve efficacy and flavor.

About FMF Racing

Owner and founder Don Emler started FMF Racing in 1973. Don’s vision was to provide the top level US racing equipment at the grass roots level. FMF was formed in Don’s garage and is now located in Rancho Dominguez in a 90,000 square foot, state-of-the-art manufacturing facility. FMF’s goal is simple; design and manufacture the world’s best performance exhaust 100% in the USA under one roof. Visit for more information.


CRN responds to JAMA study on saw palmetto

CRN responds to JAMA study on saw palmetto

In response to the published study, “Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms1,” published in JAMA (the Journal of the American Medical Association), the Council for Responsible Nutrition (CRN), the leading trade association representing the dietary supplement industry, issued the following statement:

Statement by Duffy MacKay, N.D., vice president, scientific and regulatory affairs, CRN:
“This is a well-designed, well-executed clinical trial but the results should not dissuade men experiencing urinary tract symptoms associated with an enlarged prostate gland (BPH) from considering saw palmetto as an option for reducing those symptoms.    

In this study, both the placebo group and the treatment group saw improvements in their symptoms, creating some limitations for interpreting results.  Although there is no clear explanation as to why the placebo group showed some improvement without intervention, it is possible that both groups may have included men whose urinary tract symptoms were not actually related to an enlarged prostate.  Further, the trial might not have been large enough or long enough to have found a statistically significant benefit in the treatment group.  With these potential limitations in mind, there are other practical things for men to consider about saw palmetto.
As a general rule, the potency of botanical dietary supplements is lower than pharmaceutical products. This helps account for the strong safety profile of dietary supplements, as reinforced by the lack of adverse effects in the study, making saw palmetto a safe choice.  The lower potency of botanicals, however, results in less immediate and dramatic effects than one would expect with pharmaceutical interventions.

Although this trial didn’t provide results as compelling as we would like to have seen, there are other studies on saw palmetto that have shown benefit.  General inflammation appears to contribute to the underlying cause of urinary tract symptoms related to an enlarged prostate. There are several nutrition and lifestyle modifications that can help to reduce the inflammation throughout the body. Saw palmetto extract in combination with other healthy habits, such as smart diet and regular exercise, is still a safe and viable option for men experiencing urinary discomfort associated with an ageing prostate.

As a naturopathic doctor, I’ve had some positive results in my own medical practice with this approach. If, after trying saw palmetto combined with lifestyle interventions, men don’t get adequate relief from urinary irritation and discomfort, they can seek additional interventions from their health care practitioner.


About The Council for Responsible Nutrition

The Council for Responsible Nutrition (CRN), founded in 1973, is a Washington, D.C.-based trade association representing dietary supplement manufacturers and ingredient suppliers. In addition to complying with a host of federal and state regulations governing dietary supplements in the areas of manufacturing, marketing, quality control and safety, our 75+ manufacturer and supplier members also agree to adhere to additional voluntary guidelines as well as CRN’s Code of Ethics. Visit

1 JAMA, September 28, 2011—Vol 306, No. 12

How NOW Foods maintains its value reputation

Functional Ingredients managing editor Hank Schultz traveled to Bloomingdale, Ill., to get an inside look at the manufacturing facilities of supplements giant NOW Foods. Here, Schultz talks with company representatives Aaron Secrist and Beth Pecenka about how NOW Foods maintains its vast product line while keeping prices low.

Know your GMOs: Hidden ingredients, safe labels and taking action

Know your GMOs: Hidden ingredients, safe labels and taking action

Buyers dedicated to non-GMO foods probably know the four main ingredients that are typically genetically engineered: corn, soy, canola, and cotton. But what about the hundreds of not-so-obvious additives derived from GMOs? Keep an eye out for these, and check Non-GMO Shopping Guide for more.


A simple sugar that can be naturally derived or chemically made from corn.

Hides in: Many sport drinks and soft drinks, baked goods, and sweets.


An emulsion derived from soy.

Hides in: Chocolates, ice creams, and desserts.


An additive made from starch (usually corn) used as a fat substitute, flavor stabilizer, and thickening agent.

Hides in: Instant soups, soda, candy, beer, and other processed goods

Certifiably non-GMONon-GMO project Verified (

Beyond purchasing USDA Organic, the Non-GMO Project label lets you know products passed through a rigorous third-party GMO-free verification system. Companies such as Silk, Nature’s Path Organic, Eden, Lundberg Family Farms, and Blue Marble Brands are already sporting the stamp.

Take a stand

Gary Hirshberg, CEO of Stonyfield Farm, on fighting GMOsGary Hirshberg, CEO of Stonyfield Farm

“What people need to understand with GE, or genetically engineered, [aka GMO] crops is that the seeds are owned by chemical companies. When we sanction the unrestricted use of GE crops, we’re sanctioning the unrestricted use of these chemicals, which are already making us sick.

I’m hopeful. As I travel the country, I hear that people want freedom of choice. Eighty-seven percent of Americans say that genetically modified foods should be labeled and that they don’t want to buy GE crops and food grown from GE seeds. Consumers care, farmers care, even nonorganic farmers care because they don’t want to be told what kind of seeds to grow and they don’t want to pay the higher costs demanded by these companies. We need to marshal a grassroots effort. We have the potential to organize into a powerful political voice, and the next 12 months is the time to do it.”

What you can do


FTC remains vigilant watchdog of deceptive advertising

FTC remains vigilant watchdog of deceptive advertising

The Federal Trade Commission (FTC) announced today a settlement with Reebok for $25 million in refunds to consumers who purchased Reebok toning shoes or apparel that claimed to strengthen and tone leg and butt muscles. In one example, Reebok claimed that EasyTone shoes tone the buttock muscles "up to 28 percent more than regular sneakers, just by walking," a statement for which the company had no substantiation, FTC said.

The FTC's complaint about Reebok is yet another example of the agency's continued effort to curb deceptive advertising claims—even for something as benign as shoes designed to tone your butt, said Carlotta Mast, editor-in-chief of and Natural Foods Merchandiser.

Indeed, the agency is looking to become more nimble in its regulatory-review process, which could lead to an uptick in its complaints. In July, the FTC announced it would for the first time seek public comments about ways to improve the process for consumers and businesses.

Deceptive advertising in the nutrition industry

The FTC is not just focused on gluteus maximus health claims; the agency is also heavily involved in food industry advertising. In October 2010, the FTC ventured into a deceptive advertising complaint with a big case featuring POM Wonderful, maker of pomegranate juice and supplements. FTC alleged that POM's unsubstantiated claims included the prevention and treatment of heart disease, prostate cancer and erectile dysfunction. The case has turned into a year-long affair and has not yet been settled.

Unlike Reebok, POM is fighting back, saying its $34 million in research provides scientific proof for its claims. In both situations, the FTC went after television advertisements, and in POM's case, a TV appearance on "The Martha Stewart Show" by POM owner Lynda Resnick.

Other cases within the nutrition industry in which the FTC has taken action this year include: herbal products company Daniel Chapter One for violating an FTC Order to discontinue deceptive claims about its "cancer-fighting" supplements; fake news websites touting açaí berry weight-loss products; and Nestlé Healthcare Nutrition's deceptive claims for its children's health drink Boost Kid Essentials.

Dr. Oz recommendations move markets

Dr. Oz recommendations move markets

Oprah Winfrey is a phenomenon in broadcast media, a personality whose penetration in popular perception is such that she long ago ceased needing to use her surname. Another personality who got his start in broadcasting on her show is gaining similar traction in the healthy products arena, except in the case of Dr. Mehmet Oz, MD, it’s the first name that has become superfluous.

"The Dr. Oz Show," launched in 2009 by Winfrey’s company Harpo Productions, has become a go-to source of health information for millions of consumers. And recommendations on his daytime TV program move markets in a way that few other media mentions can, even the ambivalent or negative stories about supplements that often appear in other mainstream media outlets.

“What he says matters. Americans are so darn unhealthy that if sound bites from Dr. Oz is what’s going to help them, then right on!” said Sylvia Tawse, founder of Fresh Ideas Group, a Boulder, Colo.-based public relations group that represents a host of well-know natural and healthy brands. "My own little focus group for Middle America is my father, who’s 75. He called me and asked, ‘Did you hear what Dr. Oz said about diet sodas?’ That to me means Dr. Oz is reaching a very mainstream audience.”

“What he says resonates with consumers,” agreed Heather Smith, a PR specialist with, who’s had some experience dealing with the show’s production staff.

Astaxanthin, a case study

Take for example the case of astaxanthin, a carotenoid ingredient with potent antioxidant and anti-inflammatory properties that’s derived from algae. A segment that first aired in January featured as a guest Dr. Joseph Mercola, DO, an alternative medicine popularizer who also markets a line of supplements. The show’s producers had asked Mercola to name a supplement that few people had heard of.

Dr. Mercola touted astaxanthin’s benefits, saying, among other things, “If you’re regularly using [astaxanthin], the odds are you can prevent cataracts.”

“This supplement is poised to become the next vitamin D,” Dr. Oz said during the same segment.

As a result, at the ingredient level, astaxanthin sales about doubled, according to Bob Capelli, vice president of sales for Cyanotech, a Kailua-Kona, Hawaii-based producer of algae ingredients. The effects were even more pronounced for some finished goods manufacturers, such as NOW Foods, based in Bloomingdale, Ill.

“His recommendations have had dramatic effects, particularly for astaxanthin, glucomannan and apple pectin,” said Neil Levin, NOW’s education manager. “We have seen 10 times growth or more in each of these products. Sometimes the sales growth is short-term and interest returns to normal by the next month. Astaxanthin has been an exception by remaining hugely popular half a year later.”

Part of the reason for astaxanthin’s staying power was its continued promotion on the part of Dr. Mercola, who operates an influential website of his own. After the show aired, Dr. Mercola launched an astaxanthin supplement with raw material supplied by Eustis, Fla.-based Valensa International.

That immediate interest can create some supply challenges that can’t be addressed as easily as printing more copies of a book when Oprah would mention a title on her show.

“Many of these niche products have few actual producers, so the supply chain is challenged to keep pace with skyrocketing demand. There have been shortages on astaxanthin, apple pectin and glucomannan this year,” said Dan Richard, national sales manager for NOW.

How accurate is the information?

Dr. Oz doesn’t always get his information spot on. Beth Lambert, CEO of Washington, N.J.-based herbal products manufacturer Herbalist & Alchemist, cited a few issues with segments on the show that focused on passionflower and artichoke. Passionflower, for example, is traditionally an herb used for relaxation formulations, she said.

“But he talked about it for weight loss,” she said. “His theory was it would make you less stressed, and when you’re stressed, you put on belly fat.”

In the case of the artichoke segment, Lambert said, a guest was displaying an artichoke globe, the fruiting portion of the plant consumers are familiar with buying in the produce aisle. But the active ingredient is actually an extract that comes from the leaf.

Lambert also noted similar inaccuracies with the way cat’s claw and Irish moss were presented on the show.

“I think he has been generally helpful,” she said. “Is everything accurate? No. Is there any harm? No.”

But, at the end of the day, “I think we’re lucky to have someone talking about supplements in a way that’s not negative,” Lambert said.

More serious issues were raised over a recent segment in which Dr. Oz revealed the results of tests on apple juice that he said revealed troublesome levels of arsenic. Experts at the Food and Drug Administration weighed in by saying the segment had not made the important distinction between the poisonous inorganic form of arsenic and the harmless organic form found in apples and in many other foods. The organic form of arsenic is ubiquitous, and citing it as a concern is irresponsible, some charged.

Don Zink, a senior scientist at the FDA’s Center for Food Safety and Applied Nutrition was quoted as saying, "We have 20 years of data from testing apple juice for arsenic, and all the data say there's simply not a health concern."

But despite this major hiccup with apple juice and some other, more minor issues with the accuracy of Dr. Oz’s information and with the precision of how it is presented, most industry sources are glad Oz is on their side.

“Programs like Dr. Oz are incredibly good for our industry,” Levin said. “He gives a professional, independent, practical and understandable view for taking supplements. Even better, Dr. Oz has not sold himself to any particular brand, so he is seen by the public as speaking the truth from science and not for dollars.”

Getting on the show

As far as how active ingredients are chosen for discussion on the show, Smith said: “Of course PR agencies are sending the show’s producers products. But they absolutely are doing the research of what’s coming out in the medical journals,” she said.

Smith suggested engaging the show’s producers via social media as one strategy to employ for suppliers seeking to place an ingredient on the show. But above all, keep it short and stay focused.

“The bottom line is you have to be persistent,” she said. "You need to know your pitch in a sentence.”